Dec 16, 2020 / 03:00PM GMT
Tracy Morris - Veracyte, Inc. - VP of Corporate Communications & IR
Good morning, everyone, and thanks for joining us today for our R&D Day, which will focus on our expanding lung cancer portfolio and share the latest data for our pipeline test into this important clinical indication. With me today from Veracyte are Bonnie Anderson, Chairman and Chief Executive Officer; Giulia Kennedy, our Chief Scientific Officer and Chief Medical Officer; and Keith Kennedy, our Chief Financial Officer and Chief Operating Officer. We also have 3 prominent physicians joining us today. You'll hear more about them shortly.
Before we begin, I'd like to remind you that various statements that we may make during this call will include forward-looking statements as defined under applicable securities laws. A discussion of forward-looking statements and risk factors related to the information we are sharing today can be found on Page 2 of our R&D presentation shown here.
I will now turn the meeting over to Keith Kennedy, Veracyte's Chief Financial Officer and Chief Operating Officer.
Veracyte Inc Lung Cancer R&D Day Conference Call (Virtual) Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers